Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.36 |
| ▸ | NPC1 | O15118 | 6/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16491486 | 0.80 | RAB9A (0.38) | RAB9ANPC1L3MBTL1HPGDPOLB | |
| SCHEMBL19112078 | 0.79 | POLB (0.38) | RAB9ANPC1L3MBTL1HPGDPOLB | |
| SCHEMBL22604966 | 0.79 | USP2 (0.43) | RAB9ANPC1L3MBTL1HPGDPOLB | |
| SCHEMBL12035164 | 0.78 | — | — | |
| SCHEMBL1695183 | 0.78 | NPC1 (0.39) | RAB9ANPC1L3MBTL1HPGDHTT | |
| SCHEMBL19320495 | 0.77 | HPGD (0.31) | HPGDPOLB | |
| SCHEMBL1695186 | 0.76 | — | — | |
| SCHEMBL19320497 | 0.75 | POLB (0.42) | RAB9ANPC1HPGDPOLBHTT | |
| SCHEMBL13923633 | 0.74 | RAB9A (0.65) | RAB9ANPC1L3MBTL1HPGDPOLB | |
| SCHEMBL15057288 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200165373-A1 | CURABLE ORGANIC POLYMER COMPRISING AT LEAST ONE ACYLUREA UNIT, ITS PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2020-05-28 | — | — | US | disclosed |
| US-10590227-B2 | Curable organic polymer comprising at least one acylurea unit, its preparation and use | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2020-03-17 | — | — | US | disclosed |
| WO-2017207461-A1 | USE OF COMPOUNDS HAVING N 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDE UNITS IN TWO-COMPONENT ADHESIVES | BASF SE (DE) | 2017-12-07 | — | — | WO | disclosed |
| US-20170253687-A1 | A CURABLE ORGANIC POLYMER COMPRISING AT LEAST ONE ACYLUREA UNIT, ITS PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2017-09-07 | — | — | US | disclosed |
| US-20170253687-A1 | A CURABLE ORGANIC POLYMER COMPRISING AT LEAST ONE ACYLUREA UNIT, ITS PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2017-09-07 | — | — | US | disclosed |
| US-9617238-B2 | 2-oxo-1,3-dioxolane-4-carboxamide building blocks, their preparation and use | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2017-04-11 | — | — | US | disclosed |
| US-9617238-B2 | 2-oxo-1,3-dioxolane-4-carboxamide building blocks, their preparation and use | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2017-04-11 | — | — | US | disclosed |
| US-20170008871-A1 | 2-HYDROXYETHYL 2-OXO-1,3-DIOXOLANE-4-CARBOXYLATES, THEIR PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2017-01-12 | — | — | US | disclosed |
| US-20170008871-A1 | 2-HYDROXYETHYL 2-OXO-1,3-DIOXOLANE-4-CARBOXYLATES, THEIR PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2017-01-12 | — | — | US | disclosed |
| EP-2794585-B1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE | CONSTR RES & TECH GMBH (DE) | 2016-06-15 | — | — | EP | disclosed |
| EP-2998331-A1 | A curable organic polymer comprising at least one acylurea unit, its preparation and use | Construction Research & Technology GmbH (DE) | 2016-03-23 | — | — | EP | disclosed |
| US-20150353521-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDE BUILDING BLOCKS, THEIR PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2015-12-10 | — | — | US | disclosed |
| US-20150353521-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDE BUILDING BLOCKS, THEIR PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2015-12-10 | — | — | US | disclosed |
| WO-2015132080-A1 | 2-HYDROXYETHYL 2-OXO-1, 3-DIOXOLANE-4-CARBOXYLATES, THEIR PREPARATION AND USE | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2015-09-11 | — | — | WO | disclosed |
| EP-2915808-A1 | 2-Hydroxyethyl 2-oxo-1,3-dioxolane-4-carboxylates, their preparation and use | Construction Research & Technology GmbH (DE) | 2015-09-09 | — | — | EP | disclosed |
| US-20150051365-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2015-02-19 | — | — | US | disclosed |
| US-20150051365-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE | SIKA TECHNOLOGY AG (CH) | 2015-02-19 | — | — | US | disclosed |
| WO-2014118268-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDE BUILDING BLOCKS, THEIR PREPARATION AND USE | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2014-08-07 | — | — | WO | disclosed |
| EP-2762471-A1 | 2-oxo-1,3-dioxolane-4-carboxamide building blocks, their preparation and use | Construction Research & Technology GmbH (DE) | 2014-08-06 | — | — | EP | disclosed |
| WO-2013092011-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353521-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDE BUILDING BLOCKS, THEIR PREPARATION AND USE | PYCR1, CBR1, NOX4 | RAB9A 3478/4885NPC1 1994/4885L3MBTL1 4649/4885 |
| US-20170008871-A1 | 2-HYDROXYETHYL 2-OXO-1,3-DIOXOLANE-4-CARBOXYLATES, THEIR PREPARATION AND USE | HAO2, OXGR1, HAO1 | RAB9A 4062/4885NPC1 4820/4885L3MBTL1 2812/4885 |
| US-20150051365-A1 | 2-OXO-1,3-DIOXOLANE-4-CARBOXAMIDES, THEIR PREPARATION AND USE | HAO2, OXGR1, AOX1 | RAB9A 4494/4885NPC1 4149/4885L3MBTL1 3914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.